NCT00503776 2017-06-20Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & DysphagiaVanderbilt-Ingram Cancer CenterPhase 2 Terminated41 enrolled 12 charts